Leading Developer of Multi-Layer Oral Thin Film CURE Pharmaceutical Completes Going Public Transaction; Company to Be Traded Using the Symbol CURR

IR Nav

 December 20, 2016 - 9:56 AM EST
Print Email Article Font Down Font Up Charts

Leading Developer of Multi-Layer Oral Thin Film CURE Pharmaceutical Completes Going Public Transaction; Company to Be Traded Using the Symbol CURR

OXNARD, Calif., Dec. 20, 2016 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC Pink:CURR), a preeminent developer and manufacturer of advanced oral thin film for use in pharmaceutical, veterinary, and buccal and dermal over-the-counter applications, announces today the completion of a going public transaction and the issuance of its new stock symbol - CURR.

“After nearly six years of intense R&D activities, CURE Pharmaceutical is pleased to finally become a publicly traded entity, and anticipates a series of exciting business development announcements in the months to come,” said Rob Davidson, CEO of CURE Pharmaceutical.

Headquartered in Oxnard, CA, CURE Pharmaceutical has developed and manufactures the most advanced oral thin film (CureFilm™) on the market today supported by its in-house, industry-leading full service cGMP manufacturing facility. CureFilm is more stable and durable than other oral thin films, with the ability to augment the dissolution for the intended rate of release through the bucal or gastrointestinal system. The technology enables differentiation within large therapeutic categories and potentially improves patient compliance, through its patented application of creating multiple layers, and sub-encapsulation of the delivered compound, potentially improving onset of action, lowering dosing, and enhancing, efficacy thereby widening the therapeutic index.

CURE Pharmaceutical is now traded under the symbol CURR.  For more information about CURE Pharmaceutical, please visit its website at www.curepharmaceutical.com

Forward-looking statements

This press release contains forward-looking statements, which are subject to a number of risks and uncertainties. All statements, other than statements of fact, including those statements with respect to the Company's business development, are forward-looking statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.

Contact:
Jules Abraham
JQA Partners, Inc.
917-885-7378
jabraham@jqapartners.com

Source: GlobeNewswire (December 20, 2016 - 9:56 AM EST)

News by QuoteMedia
www.quotemedia.com
IR website by IR WebKit